You are here: Industry Insights > COVID-19

News List

Roivant Doses First Patient in Pivotal BREATHE Clinical Trial Evaluating Gimsilumab in COVID-19 Patients for the Prevention and Treatment of Acute Respiratory Distress Syndrome prnewswire
April 16, 2020
Roivant Sciences announced that the first patient was dosed at Temple University Hospital in Philadelphia in an adaptive, randomized, double-blind, placebo-controlled ...
Heritage Christian Services Launches COVID-19 Screening and Tracking Hotline to Help Stem the Spread of the Coronavirus prnewswire
April 16, 2020
Heritage Christian Services has launched a COVID-19 hotline for employees and those who use its services to report symptoms and get help.
A dive into COVID-19 treatment avenues expresspharma
April 16, 2020
“Frost & Sullivan’s analysis reveals that hydroxychloroquine and Remdesivir are likely to emerge as important treatment strategies for COVID-19,” ...
India agrees to sell hydroxychloroquine to Malaysia to help fight COVID-19 expresspharma
April 16, 2020
India has agreed to sell hydroxychloroquine (HCQ) tablets to Malaysia for use in the treatment of COVID-19 patients, a Malaysian minister told Reuters recently, with New Delhi partially lifting its bar on exports of the anti-malarial drug.
Ridgeback Biotherapeutics announces MHRA clearance to begin human testing of EIDD-2801 in UK for COVID-19 pharmaceutical-business-review
April 16, 2020
Ridgeback Biotherapeutics announced clearance by the UK Medicines and Healthcare products Regulatory Agency (MHRA).
Hope Biosciences gets FDA nod for phase 2 COVID-19 stem cell therapy trial pharmaceutical-business-review
April 16, 2020
Hope Biosciences has been given clearance from the US Food and Drug Administration (FDA) to move ahead with a phase 2 trial to evaluate its investigational stem cell therapy in providing immune support against COVID-19.
AstraZeneca Initiates Calquence Clinical Trial against COVID-19 americanpharmaceuticalreview
April 16, 2020
AstraZeneca will initiate a randomized, global clinical trial to assess the potential of Calquence (acalabrutinib) in the treatment of the exaggerated immune response (cytokine storm) associated with COVID-19 infection in severely ill patients.
Xylyx Bio Offers Advanced Lung Models to Accelerate COVID-19-Related Drug Development americanpharmaceuticalreview
April 16, 2020
Xylyx Bio announced availability of products that recreate the lung environment in vitro to provide a predictive model.
BD Announces Second FDA Emergency Use Authorization, CE Mark for COVID-19 Molecular Diagnostic americanpharmaceuticalreview
April 16, 2020
BD announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for an additional molecular diagnostic test for COVID-19.
FDA grants emergency use authorisation to blood purification system for COVID-19 europeanpharmaceuticalreview
April 16, 2020
A blood purification system to reduce cytokine storms in COVID-19 patients has been given emergency use authorisation by the FDA.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 437 438 Next page